Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
After three months on the medication, that dropped to 11.5%
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Statistical Analysis All data were shown as means SEM
At 48 h, apoptosis was evaluated with Annexin V (1:500 v/v, Invitrogen) and DAPI (0.1 g/mL, Sigma-Aldrich) staining
US$ 26.14
US$ 22.14
US$ 21.72
US$ 20.35
US$ 25.22
US$ 26.63
US$ 25.44
